<DOC>
	<DOC>NCT00816101</DOC>
	<brief_summary>The purpose of this pilot clinical study is to compare healing rates, pain levels, and incidence of wound complications including infection with the use of a moist PROCELLERA™ Antimicrobial Wound Dressing when compared to a standard dressing, Mepilex® Border Lite, following curettage and electrodesiccation of skin lesions.</brief_summary>
	<brief_title>Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>If female, must either be not of childbearing potential or if they are of childbearing potential must have a negative urine pregnancy test. Wound size greater than 1x1 cm Wounds must be ≥5 cm away from all other wounds Wound size must not be diminished in size greater than 10% between enrollment in study and the prescreening Participant agrees to participate in followup evaluation Participant must be able to read and understand informed consent, and sign the informed consent Concurrent participation in another clinical trial that involves an investigational drug or device that would interfere with this study Participant is to receive another topical antimicrobial agent other than the study dressing Participant with sensitivity or adverse reactions to silver or zinc Pregnancy or nursing an infant or child Immunosuppression Active or systemic infection Peripheral vascular occlusive disease Collagen vascular disease Connective tissue disease Diabetes Venous stasis ulcers Participant undergoing active cancer chemotherapy Chronic steroid use Decision impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Curettage and electrodesiccation</keyword>
	<keyword>acute wounds</keyword>
	<keyword>partial thickness wounds</keyword>
</DOC>